Tuesday, June 16, 2026

UAE Pharmaceutical Distribution Reform: What the End of Single-Agent Arrangements Means for the Industry

UAE Pharmaceutical Distribution Reform: What the End of Single-Agent Arrangements Means for the Industry
UAE Pharmaceutical Distribution Reform: What the End of Single-Agent Arrangements Means for the Industry

The UAE is reshaping how pharmaceutical products reach the market. Effective from February 2026, the Emirates Drug Establishment has introduced a requirement for pharmaceutical companies to appoint more than one authorized local agent per product — ending the single-agent distribution model that has long defined market access in the country.

Why the Reform Was Needed

The existing model concentrated supply chain risk with individual distributors. Any disruption — inventory shortages, cold-chain failures, financial disputes, or compliance issues — affecting a sole agent could affect medicine availability across the entire UAE market. The new mechanism, implemented under Federal Decree-Law No. 38 of 2024, is designed to eliminate that vulnerability and ensure supply continuity, particularly for essential and specialised medicines.

Market Context: A Sector Projected to Reach US$8 Billion

The UAE pharmaceutical market generated an estimated US$5 billion in revenue in 2025 and is projected to reach US$8 billion by 2033, growing at around 6% annually. Biologics, biosimilars, and oncology treatments are among the fastest-growing segments — all requiring reliable cold-chain logistics and uninterrupted distribution.

Commercial Implications for Manufacturers and Distributors

For international pharmaceutical companies, the reform requires a review of existing agency agreements, particularly any exclusivity provisions. A multi-agent model can improve supply resilience and channel specialisation, but requires clearer governance on stock allocation, pricing consistency, and partner responsibilities.

For UAE-based distributors, the reform creates both pressure and opportunity. Those with strong logistics infrastructure, digital inventory systems, and hospital tendering expertise are well-placed to expand their portfolio of authorised products.

The reform signals that distribution resilience is now a regulatory priority in the UAE — and a key component of the country’s ambition to become a leading regional life sciences hub.

For more trusted business news, market insights, and investment updates from the UAE and beyond, visit www.moneypetrol.com and stay ahead of the curve.

Watch & subscribe to MoneyPetrol podcasts on YouTube for in-depth conversations with industry leaders and decision-makers.

Follow us on Instagram for real-time updates, expert perspectives, and exclusive content.

Real-time UAE business news straight to your device. — Enable notifications now!

Related Posts

RGCC Contracting RGCC Contracting RGCC Contracting
ADVERTISEMENT

Recommended Stories

RG Estate RG Estate RG Estate
ADVERTISEMENT

Welcome Back!

Login to your account below

Create New Account!

Fill the forms bellow to register

Retrieve your password

Please enter your username or email address to reset your password.

Add New Playlist

Get our free newsletter delivered daily to your inbox—subscribe now!

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?
-
00:00
00:00
Update Required Flash plugin
-
00:00
00:00